Drug Tables

Alphabetical Listing of individual drugs

a b c d e f g h i j k l m
n o p q r s t u v w x y z

Drug Categories (New)

Note: selected new drug releases are added to the alphabetical listing below

Navigation

a

Ace Inhibitors
ACLS 2010 (previous guidelines)
Acne (topical Agents)
Actinic Keratosis
Addiction Aids
Aldosterone Antagonists
Alpha Blockers
ALS Agents
Alzheimer's Disease - Therapeutic agents
Aminoglycosides
AMYLIN AGONISTS - Anti-hyperglycemic Synthetic Analogs
Anesthetics / Sedatives
Angiotensin II inhibitors
Antacids
Anti-Arrhythmics
Anti-cholinergics
Anti-Convulsants
Antidepressants
Anti-Diarrheals
Anti-Emetics
Anti-Fungals
Anti-Hepatitis Agents
Anti-Herpetic Agents
Anti-Hypertensive combinations
Anti-Hypertensive (Other)
Anti-Influenza Agents
Anti-Malarials
Anti-Platelet agents
Anti-Psychotics
Anti-Spasmotics (Bowel)
Antibiotics (Other)
Antihistamines
Antitussives /Expectorants
Atopic Dermatitis

b

Benzodiazepines
Beta Blockers
Bile Acid Sequestrants
Biological response modifiers (BRMs) - TNF inhibitors
Bisphosphonates
Bladder spasm
BPH

c

Calcium Channel Blockers
Calcium Supplements
Carbapenems
Cephalosporins
Colony Stimulating Factors
Combination Insulins
Combination Products
Contraceptives
Corticosteroids (intra-articular)
Corticalsteroids (topical) potency
Corticosteroids (Systemic)
Cystic Fibrosis - Newer agents

d

Decongestants
Diabetes: Alpha-glucosidase Inhibitors
Biguanides e.g. Metformin
DPP-4 INHIBITORS - Dipeptidyl peptidase-4 inhibitor - Gliptins
Glitazones - Thiazolidinediones
Glucagon-like peptide-1 (GLP-1) AGONIST - Incretin Mimetics
Meglitinides (e.g. Prandin)
Diabetes: Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Sulfonylureas
Direct thrombin inhibitors
Diuretics
Drug / Food Interactions
Therapeutic drug levels
Diabetes:
Secretagogues
Antidepressant discontinuation syndrome
Glaucoma Alpha-adrenergic agonists
Comparative effectiveness of glaucoma drops
Glaucoma benzalkonium chloride Free products
Glaucoma Preservative-Free drops
Insulin sensitizers
Antidepressant discontinuation syndrome
Glaucoma Alpha-adrenergic agonists
Comparative effectiveness of glaucoma drops
Glaucoma benzalkonium chloride Free products
Glaucoma Preservative-Free drops
Alpha-glucosidase inh
Antidepressant discontinuation syndrome
Glaucoma Alpha-adrenergic agonists
Comparative effectiveness of glaucoma drops
Glaucoma benzalkonium chloride Free products
Glaucoma Preservative-Free drops
Peptide analogs
Antidepressant discontinuation syndrome
Glaucoma Alpha-adrenergic agonists
Comparative effectiveness of glaucoma drops
Glaucoma benzalkonium chloride Free products
Glaucoma Preservative-Free drops
Insulin Products
Antidepressant discontinuation syndrome
Glaucoma Alpha-adrenergic agonists
Comparative effectiveness of glaucoma drops
Glaucoma benzalkonium chloride Free products
Glaucoma Preservative-Free drops

e - f - h

Endocrine / Other
Erectile dysfunction
Fever inducing agents
Fibrates
Fibromyalgia
Fluoroquinolones
Fusion inhibitors, CCR5 Antag, integrase strand transfer inhib.
G6PD deficiency
Gastrointestinal (Other)
Gout

h - i -j

H2 Blockers
Helicobacter Pylori
Hemorrhoids
HIV (anti) Agents
Hormone replacement
Hypertensive Emergency (IV)
Hypertensive Urgency (oral)
Immunizations
Infectious disease drug list
Inflammatory bowel disease
Insulin's
Interferons
Interleukin-5 antagonists
Intermediate-Acting Insulins
Intermittent Claudication
Irritable Bowel Syndrome

k - l - m

COMMON LAB VALUES – NORMAL LABORATORY REFERENCE RANGES
Laxatives
Lipid lowering- alternative agents
Long-Acting Insulins
Low Molecular Weight Heparins and Anti-Xa agents
Macrolides
Magnesium supplements
Migraine
Mouth & Lip preparations (topical)
Multiple sclerosis
Muscle relaxants

n - o - p - q

Nasal preparations
Neuromuscular blocking agents
Neutropenia (Agents causing)
Nitrates
Non-Nucleoside Reverse Transcriptase Inhibitors
NSAIDs
Nucleoside Reverse Transcriptase Inhibitors
Oncology Intravenous IV Dilution - Parenteral Agents
Oncology related (including new drugs, antagonists, etc)
Ophthalmic Preparations
Opiates / Combination
Otic Preparations
Parkinsons Disease
PCA - Patient Controlled Analgesia
PCSK9 inhibitors
Penicillins
Periodic table
Phosphate supplements
phosphodiesterase 4 (PDE4) inh
Postmenopausal agents
Potassium supplements
Prostate Cancer
Protease Inhibitors
Prothrombin concentrates / complexes
Proton pump inhibitors
Psoriasis
Pulmonary fibrosis (idopathic) -(IPF)
Pulmonary Hypertension

r - s - t

Rapid-Acting Analogues
Renal Failure (agents)
Respiratory Medications
Restless legs syndrome (RLS)
Rheumatoid arthritis
Sclerosing agents
Short-Acting Insulins
Sore throat
Statins - Cholesterol lowering agents
Stimulants
Tardive Dyskinesia
Tetracyclines
Thrombocytopenia (causative)
Thrombolytics
Thyroid (Anti)
Thyroid Hormone
Topical (Anti-fungals)
Topical (Antibacterials)
Topical (Antiparasitics)
Topical (Burns)
Topical (Corticosteroids)
Topicals (Antiviral)
Topicals (Other)
Toxicology
Tuberculosis agents

u - v - w - x - y - z

Urinary (Other)
Urine discoloration
Urology - Dysuria
Vaginal Preparations
Vasodilators
Vasopressin-V2- receptor-antagonists
Vasopressors and inotropes
Vitamin D Analogs
Weight Management Agents
Women's Health

< Disclaimer >
David F. McAuley, Pharm.D., R.Ph.GlobalRPh Inc.

< Medical Articles >
What are the current recommendations regarding the use of vasopressin in the treatment of shock? Antibiotic therapies appropriate for the treatment of uncomplicated sinus infections Cholestyramine and its role in C. difficile infections
How effective is docusate as a cerumenolytic agent? Melatonin and its use in the treatment  of tardive dyskinesia Current dosing recommendations for naloxone in treating pruritus associated with cholestasis
How does pregabalin compare to gabapentin in the treatment of neuropathic pain? Ruboxistaurin mesylate and its role in treating diabetic nephropathy The current role of sildenafil citrate in the treatment of pulmonary arterial hypertension

 

Drugs